Viewing Company
Company Name:
Raphael Pharmaceutical Inc.
CIK:
1415397
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2021-11-16
Last Filing Date:
2025-03-31
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-16 | 0001213900-21-059980 | $ 12,131,663 | View |
| 2022-01-01 | 2022-03-31 | CY2021Q1 | 2022-05-16 | 0001213900-22-026790 | $ 13,035,371 | View |
| 2022-01-01 | 2022-03-31 | CY2022Q1 | 2023-05-15 | 0001213900-23-039833 | $ 150,000 | View |
| 2021-01-01 | 2021-12-31 | CY2021 | 2022-03-30 | 0001213900-22-015973 | $ 1 | View |
| 2022-04-01 | 2022-06-30 | CY2021Q2 | 2022-08-12 | 0001213900-22-047195 | $ 13,647,151 | View |
| 2022-01-01 | 2022-09-08 | CY2022Q3I | 2022-11-14 | 0001213900-22-071861 | $ 102,000 | View |
| 2023-05-01 | 2023-05-31 | CY2023Q2I | 2023-08-09 | 0001213900-23-065005 | $ 123,000 | View |
| 2022-01-01 | 2022-09-30 | CY2023Q3I | 2023-11-14 | 0001213900-23-086894 | $ 2,000 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1 | 2024-05-15 | 0001213900-24-043557 | $ 50,000 | View |
| 2024-01-01 | 2024-01-31 | CY2023Q4I | 2024-08-12 | 0001213900-24-067723 | $ 58,500 | View |
| 2024-01-01 | 2024-09-30 | CY2024Q3I | 2024-11-14 | 0001213900-24-098456 | $ 2,000 | View |
| 2023-01-01 | 2023-11-30 | CY2023Q4I | 2025-03-31 | 0001213900-25-026214 | $ 200,500 | View |
| 2022-01-01 | 2022-10-26 | CY2022 | 2023-03-24 | 0001213900-23-022628 | $ 100,000 | View |
| 2022-01-01 | 2022-12-31 | CY2022 | 2023-05-25 | 0001213900-23-043104 | $ 2,090,000 | View |
| 2023-01-01 | 2023-12-31 | CY2023 | 2024-03-28 | 0001213900-24-027234 | $ 500,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Liabilities Subject to Compromise, Early Contract Termination Fees | The amount of early contract termination fees included in liabilities subject to compromise. | View |
| us-gaap | Excess Stock, Shares Authorized | Maximum number of excess stock shares permitted to be issued. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits. | View |
| us-gaap | Excess Stock, Shares Issued | Number of excess stock shares of an entity that have been sold or granted to shareholders. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Other Current Assets | Amount of increase (decrease) in current assets classified as other. | View |
| us-gaap | Investments | Sum of the carrying amounts as of the balance sheet date of all investments. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Noncash Merger Related Costs | Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Other Assets, Current | Amount of current assets classified as other. | View |
| us-gaap | Payments for Merger Related Costs | The amount of cash paid during the reporting period for charges associated with the mergers. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Proceeds from Debt, Net of Issuance Costs | The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | View |
| us-gaap | Short-term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. | View |
| us-gaap | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Accrued Liabilities | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Class of Warrant or Right, Outstanding | Number of warrants or rights outstanding. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | View |
| us-gaap | Conversion of Stock, Shares Issued | "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Cost, Maintenance | Cost of maintenance incurred and directly related to good produced and service rendered. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Due to Related Parties, Current | Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. | View |
| us-gaap | Increase (Decrease) in Due to Related Parties | The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence. | View |
| us-gaap | Legal Fees | The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. | View |
| us-gaap | Notes Payable | Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Operating Loss Carryforwards | Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. | View |
| us-gaap | Other Expenses | Amount of expense classified as other. | View |
| us-gaap | Other Notes Payable | Amount of long-term notes payable classified as other. | View |
| us-gaap | Prepaid Expense | Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. | View |
| us-gaap | Professional and Contract Services Expense | Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support. | View |
| us-gaap | Professional Fees | A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Receivables from Brokers-Dealers and Clearing Organizations | Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables. | View |
| us-gaap | Revenue from Related Parties | Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. | View |
| us-gaap | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Warrant, Exercise Price, Decrease | Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. | View |
| us-gaap | Warrant, Exercise Price, Increase | Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Proceeds from Issuance of Warrants | The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). | View |
| us-gaap | Stock Issued During Period, Shares, Reverse Stock Splits | Reduction in the number of shares during the period as a result of a reverse stock split. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Investment Company, Committed Capital | Amount of funds committed to investment company from investors. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Shares Issued, Price Per Share | Per share or per unit amount of equity securities issued. | View |
| us-gaap | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Payments to Acquire Other Productive Assets | Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other. | View |
| us-gaap | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | View |
| us-gaap | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | APIC, Share-based Payment Arrangement, Recognition and Exercise | Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. | View |
| us-gaap | Class of Warrant or Right, Unissued | The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights. | View |
| us-gaap | Compensation and Benefits Trust | The value of a trust established to hold the stock of an employee compensation and benefits plan as of the balance sheet date. | View |
| us-gaap | Debt Conversion, Converted Instrument, Warrants or Options Issued | "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Equity Method Investment, Aggregate Cost | This element represents the aggregate cost of investments accounted for under the equity method of accounting. | View |
| us-gaap | Other General Expense | Amount of general expenses not normally included in Other Operating Costs and Expenses. | View |
| us-gaap | Payments for Other Fees | Amount of cash outflow for fees classified as other. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Public Utilities, Approved Equity Capital Structure, Percentage | Percentage of public utility's approved equity to capital, including debt and equity. | View |
| us-gaap | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party. | View |
| us-gaap | Research and Development Expense, Software (Excluding Acquired in Process Cost) | Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Stockholders' Equity, Other Shares | Number of increase (decrease) in shares of stock classified as other. | View |
| us-gaap | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | View |
| us-gaap | Stock Option, Exercise Price, Increase | Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. | View |
| us-gaap | Warrants and Rights Outstanding | Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Equity Method Investment, Quoted Market Value | This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available. | View |
| us-gaap | Retained Earnings, Unappropriated | A segregation of retained earnings which is available for dividend distribution. Earnings not paid out as dividends but instead reinvested in the core business or used to pay off debt. Unappropriated profit is part of shareholder equity. Also called cumulative distributions or earned surplus or accumulated earnings or unappropriated profit. | View |
| us-gaap | Stock Issued | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Employee Benefit and Share-based Payment Arrangement, Noncash | Amount of noncash expense (reversal of expense) for employee benefits and share-based payment arrangement. Includes, but is not limited to, pension, other postretirement, postemployment and termination benefits. | View |
| us-gaap | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. | View |
| us-gaap | Other Cost and Expense, Operating | The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. | View |
| us-gaap | Transfer to Investments | Value of investments transferred to the entity's investments in noncash transactions. | View |
| us-gaap | Common Stock, Value, Outstanding | Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares. | View |
| us-gaap | Construction Contractor, Receivable, Retainage | Amount of right to consideration in exchange for good or service transferred to customer withheld under retainage provision in long-term contract or program when right to consideration is unconditional. | View |
| us-gaap | Other Accounts Payable and Accrued Liabilities | Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer. | View |
| us-gaap | Payments to Acquire Productive Assets | The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. | View |
| us-gaap | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. | View |
| us-gaap | Costs and Expenses, Related Party | Costs of sales and operating expenses for the period incurred from transactions with related parties. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Other Receivables | Amount due from parties in nontrade transactions, classified as other. | View |
| us-gaap | Other Research and Development Expense | Amount of other research and development expense. | View |
| us-gaap | Payments for Operating Activities | Total amount of cash paid for operating activities during the current period. | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Related Party Deposit Liabilities | Amount of deposits held by the entity for a related party (entity, shareholder, employee). | View |
| us-gaap | Related Party Tax Expense, Due to Affiliates, Current | The amount of any current tax-related balances due to affiliates as of the date of each statement of financial position presented. | View |
| us-gaap | Related Party Transaction, Amounts of Transaction | Amount of transactions with related party during the financial reporting period. | View |
| us-gaap | Capital Units, Cost to Investors | Cost to investors of each class of capital shares or other capital units. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Proceeds from Other Equity | Amount of cash inflow from the issuance of equity classified as other. | View |
| us-gaap | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. | View |
| us-gaap | Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares | Change in number of shares issued and outstanding as a result of capital structure change to a stock dividend, stock split or reserve split occurring after the balance sheet date but prior to the later of the issuance of financial statements or the effective date of registration statement. | View |
| us-gaap | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Accounts Payable | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Proceeds from Convertible Debt | The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Temporary Equity, Stock Issued During Period, Value, New Issues | Value of new stock classified as temporary equity issued during the period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Accounts Payable and Accrued Liabilities | Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations. | View |
| us-gaap | Interest and Fee Income, Loans and Leases | The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Line of Credit Facility, Commitment Fee Percentage | The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used. | View |
| us-gaap | Increase (Decrease) in Accounts Payable, Related Parties | The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. | View |
| us-gaap | Common Stocks, Including Additional Paid in Capital, Net of Discount | Amount after discount on shares of par value plus amounts in excess of par value or issuance value for common stock held by shareholders. Includes common stock repurchased and held as treasury stock. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Share-based Payment Arrangement, Expense, after Tax | Amount, after tax, of expense for award under share-based payment arrangement. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. | View |
| us-gaap | Number of Operating Segments | Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. | View |
| us-gaap | Other General and Administrative Expense | Amount of general and administrative expense classified as other. | View |
| us-gaap | 4254772 | None | View |
| us-gaap | Stockholders' Equity Note, Subscriptions Receivable | Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital. | View |
| us-gaap | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Common Stock, Value, Issued | View |
| Accounts Payable and Other Accrued Liabilities, Current | View |
| Accounts Payable, Current | View |
| Additional Paid in Capital | View |
| Assets | View |
| Assets, Current | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Excess Stock, Shares Issued | View |
| General and Administrative Expense | View |
| Increase (Decrease) in Accounts Payable | View |
| Investments | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Noncash Merger Related Costs | View |
| Nonoperating Income (Expense) | View |
| Operating Income (Loss) | View |
| Other Assets, Current | View |
| Proceeds from Debt, Net of Issuance Costs | View |
| Proceeds from Issuance of Common Stock | View |
| Research and Development Expense | View |
| Retained Earnings (Accumulated Deficit) | View |
| Shares, Issued | View |
| Short-term Debt | View |
| Stockholders' Equity Attributable to Parent | View |
| Stock Issued During Period, Shares, New Issues | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Other | View |
| Temporary Equity, Stock Issued During Period, Value, New Issues | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Accrued Liabilities | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| Class of Warrant or Right, Outstanding | View |
| Common Stock, Shares Authorized | View |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | View |
| Conversion of Stock, Shares Issued | View |
| Cost, Maintenance | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Due to Related Parties, Current | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | View |
| Income (Loss) from Continuing Operations, Per Basic and Diluted Share | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | View |
| Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | View |
| Increase (Decrease) in Due to Related Parties | View |
| Interest and Fee Income, Loans and Leases | View |
| Legal Fees | View |
| Net Income (Loss) Available to Common Stockholders, Basic | View |
| Notes Payable | View |
| Operating Loss Carryforwards | View |
| Other Expenses | View |
| Other Notes Payable | View |
| Prepaid Expense | View |
| Professional and Contract Services Expense | View |
| Professional Fees | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Receivables from Brokers-Dealers and Clearing Organizations | View |
| Revenue from Related Parties | View |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Warrant, Exercise Price, Decrease | View |
| Earnings Per Share, Basic | View |
| Proceeds from Issuance of Warrants | View |
| Stock Issued During Period, Shares, Reverse Stock Splits | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Earnings Per Share, Diluted | View |
| Investment Company, Committed Capital | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Stock Issued During Period, Value, Issued for Services | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Finite-Lived Intangible Assets, Net | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Payments to Acquire Other Productive Assets | View |
| Treasury Stock, Common, Shares | View |
| Accounts Payable and Accrued Liabilities, Current | View |
| Accrued Liabilities, Current | View |
| APIC, Share-based Payment Arrangement, Recognition and Exercise | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | View |
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | View |
| Class of Warrant or Right, Unissued | View |
| Compensation and Benefits Trust | View |
| Debt Conversion, Converted Instrument, Warrants or Options Issued | View |
| Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | View |
| Equity Method Investment, Aggregate Cost | View |
| Excess Stock, Shares Authorized | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Liabilities Subject to Compromise, Early Contract Termination Fees | View |
| Line of Credit Facility, Commitment Fee Percentage | View |
| Other General Expense | View |
| Payments for Other Fees | View |
| Payments of Stock Issuance Costs | View |
| Public Utilities, Approved Equity Capital Structure, Percentage | View |
| Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | View |
| Research and Development Expense, Software (Excluding Acquired in Process Cost) | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Stockholders' Equity, Other Shares | View |
| Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | View |
| Stock Option, Exercise Price, Increase | View |
| Warrants and Rights Outstanding | View |
| Depreciation | View |
| Equity Method Investment, Quoted Market Value | View |
| Increase (Decrease) in Accounts Payable, Related Parties | View |
| Retained Earnings, Unappropriated | View |
| Stock Issued | View |
| Employee Benefit and Share-based Payment Arrangement, Noncash | View |
| Notes Payable, Current | View |
| Other Cost and Expense, Operating | View |
| Transfer to Investments | View |
| Common Stock, Value, Outstanding | View |
| Construction Contractor, Receivable, Retainage | View |
| Other Accounts Payable and Accrued Liabilities | View |
| Payments to Acquire Productive Assets | View |
| Additional Paid in Capital, Common Stock | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| Common Stocks, Including Additional Paid in Capital, Net of Discount | View |
| Costs and Expenses, Related Party | View |
| Deferred Tax Assets, Gross | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | View |
| Other Receivables | View |
| Other Research and Development Expense | View |
| Payments for Operating Activities | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Prepaid Expense, Current | View |
| Related Party Deposit Liabilities | View |
| Related Party Transaction, Amounts of Transaction | View |
| Capital Units, Cost to Investors | View |
| Proceeds from Warrant Exercises | View |
| Proceeds from Other Equity | View |
| Proceeds from (Payments for) Other Financing Activities | View |
| Stock Issued During Period, Shares, Other | View |
| Property, Plant and Equipment, Net | View |
| Earnings Per Share, Basic and Diluted | View |
| Increase (Decrease) in Other Current Assets | View |
| Payments for Merger Related Costs | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Proceeds from Convertible Debt | View |
| Accounts Payable and Accrued Liabilities | View |
| Accounts Payable | View |
| Warrant, Exercise Price, Increase | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Shares Issued, Price Per Share | View |
| Related Party Tax Expense, Due to Affiliates, Current | View |
| Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Share-based Payment Arrangement, Expense, after Tax | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | View |
| Number of Operating Segments | View |
| Other General and Administrative Expense | View |
| 4217719 | View |
| Stockholders' Equity Note, Subscriptions Receivable | View |
| Stock Issued During Period, Shares, Issued for Services | View |